Virtus Investment Partners EBITDA 2011-2026 | VRTS

Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.^[1]

EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.

EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.

However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.

Annual EBITDA Virtus Investment Partners

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
251 M	222 M	266 M	376 M	182 M	162 M	143 M	84.3 M	60.6 M	87.1 M	138 M	121 M	68 M	21.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
376 M	21.8 M	156 M

Quarterly EBITDA Virtus Investment Partners

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
49 M	47.2 M	52.7 M	-	57.6 M	46.5 M	50.5 M	-	46.4 M	40.5 M	45 M	-	45 M	57.6 M	81.5 M	-	128 M	110 M	73.4 M	50.9 M	73.2 M	48.2 M	35.5 M	37.8 M	65.6 M	49.9 M	30.9 M	29.2 M	57.1 M	40.9 M	29.4 M	28 M	28.4 M	8.08 M	11 M	12.8 M	21 M	11.8 M	14.3 M	16.5 M	28.4 M	19.6 M	26.2 M	36.7 M	44 M	25.8 M	34.3 M	33.9 M	36.9 M	27.5 M	22.8 M	20.5 M	18.2 M	14.7 M	8.28 M	8.19 M	-1.74 M	3.94 M	4.93 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
128 M	-1.74 M	37.2 M

References

Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.

EBITDA of other stocks in the Diversified financials industry

Issuer	EBITDA	Price	% 24h	Market Cap	Country
Арсагера ARSA	-7.94 M	-	-	-	Russia
Equus Total Return, Inc. EQS	-0.679	$ 1.13	-6.33 %	$ 15.3 M	USA
Jupai Holdings Limited JP	5.3 M	-	0.98 %	$ 12.7 M	-
Altisource Asset Management Corporation AAMC	247 K	-	-1.53 %	$ 3.77 M	USA
Ares Capital Corporation ARCC	1.21 B	$ 18.86	1.37 %	$ 7.98 B	USA
FS KKR Capital Corp. FSK	562 M	$ 10.68	1.67 %	$ 1.32 B	USA
Ashford AINC	36.2 M	-	0.2 %	$ 15.3 M	USA
Blucora BCOR	26.4 M	-	-0.29 %	$ 1.31 B	USA
BrightSphere Investment Group BSIG	132 M	-	-0.11 %	$ 1.09 B	Britain
AssetMark Financial Holdings AMK	35.5 M	-	-	$ 2.61 B	USA
МЕРИДИАН MERF	-47.2 M	-	-	-	Russia
Русс-Инвест RUSI	12.4 M	-	-	-	Russia
Сафмар SFIN	10.6 B	-	-	-	Russia
Atlas Corp. ATCO	1.13 B	-	-0.1 %	$ 4.45 B	China
Capital Southwest Corporation CSWC	5.86 M	$ 23.55	-0.31 %	$ 1.12 B	USA
Investcorp Credit Management BDC, Inc. ICMB	45.4 M	$ 1.86	-1.59 %	$ 25.6 M	USA
Rand Capital Corporation RAND	37.7 K	$ 10.89	0.9 %	$ 24.7 M	USA
Tekla Healthcare Investors HQH	-288 M	$ 19.59	-0.13 %	$ 839 M	USA
Diamond Hill Investment Group DHIL	45.1 M	$ 174.99	-	$ 483 M	USA
Stellus Capital Investment Corporation SCM	34.9 M	$ 9.67	1.15 %	$ 188 M	USA
SEI Investments Company SEIC	642 M	$ 91.51	0.49 %	$ 11.2 B	USA
Tekla Life Sciences Investors HQL	-138 M	$ 17.52	-0.26 %	$ 406 M	USA
SLR Investment Corp. SLRC	119 M	$ 15.6	0.91 %	$ 659 M	USA
StepStone Group STEP	45.5 M	$ 51.08	2.32 %	$ 3.63 B	USA
Hamilton Lane Incorporated HLNE	7.44 M	$ 91.52	2.3 %	$ 3.95 B	USA
Apollo Investment Corporation AINV	-373 M	-	0.52 %	$ 730 M	USA
Ares Management Corporation ARES	32.2 M	$ 111.23	-0.85 %	$ 34.8 B	USA
CI Financial Corp CIXX	937 M	-	-0.7 %	$ 2.9 B	-
Brookfield Asset Management BAM	2.68 B	$ 46.45	-1.09 %	$ 51.5 B	Canada
Eaton Vance Corp. EV	378 M	-	-0.98 %	$ 8.58 B	USA
Harvest Capital Credit Corporation HCAP	-1.21 M	-	-	$ 57.7 M	USA
Medley Management Inc. MDLY	-3.99 M	-	-	$ 18.3 M	USA
Puhui Wealth Investment Management Co., Ltd. PHCF	-3.65 M	-	-	$ 5.54 M	China
Puyi PUYI	-68.5 M	-	33.93 %	$ 811 M	China
T. Rowe Price Group TROW	2.19 B	$ 100.81	-0.55 %	$ 22.2 B	USA
Waddell & Reed Financial, Inc. WDR	107 M	-	-0.04 %	$ 1.55 B	USA